Latest filing published 10 Dec 2007 for Sangamo Therapeutics, INC, €67k.
Insider track record
No signal scores available.
William G. Gerber: trading record in brief
This profile gathers the share dealings of William G. Gerber across 2 companies, led by Sangamo Therapeutics, Inc and Nanogen Inc. In total, 9 filings cover trades dated from 9 June 2005 to 6 December 2007.
Every open-market trade on record is a sale: 7 sales worth €250k. Besides market trades, the filings include 2 share grants. So far in 2007, the count stands at no purchases and 7 sales.
On 10 December 2007 came the latest disclosure, an open-market sale for €67k in Sangamo Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to William G. Gerber
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 6,100 shares@ US$16.00Common StockSEC:0001209191-07-068837:0
- 5,000 shares@ US$13.34Common StockSEC:0001209191-07-055078:0
- 446 shares@ US$10.86Common StockSEC:0001209191-07-050914:0
- 4,554 shares@ US$10.87Common StockSEC:0001209191-07-050914:1
- 5,000 shares@ US$9.66Common StockSEC:0001209191-07-043880:0
- 5,000 shares@ US$8.50Common StockSEC:0001209191-07-039122:0
- 5,000 shares@ US$8.00Common StockSEC:0001209191-07-038175:0
7 of 7 declarations
